<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Rapamune; Sirolimus" /><meta name="IX" content="Rapamune; Sirolimus" /><title>Rapamune®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP5638-rapamune.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP5638-rapamune.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP5638-rapamune.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 08 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP5179-malignant-disease-and-immunosuppression.htm">8 Malignant disease and immunosuppression</a> &gt; <a href="PHP5590-drugs-affecting-the-immune-response.htm">8.2 Drugs affecting the immune response</a> &gt; <a href="PHP5614-corticosteroids-and-other-immunosuppressants.htm">8.2.2 Corticosteroids and other immunosuppressants</a> &gt; <a href="PHP5637-sirolimus.htm">SIROLIMUS</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP5626-ciclosporin.htm" title="Previous: CICLOSPORIN">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP5639-tacrolimus.htm" title="Next: TACROLIMUS">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a300009.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Sirolimus</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Miscellaneous Therapeutic Agents 92:00 &gt; Immunosuppressive Agents 92:44</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/8273-e.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Sirolimus</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: S &gt; Interactions of Sirolimus</p></div></li></ul><ul><li><h3>British National Formulary (2)</h3></li><li><a href="PHP5614-corticosteroids-and-other-immunosuppressants.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">8.2.2 Corticosteroids and other immunosuppressants</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response</p></div></li><li><a href="PHP5637-sirolimus.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">SIROLIMUS</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response &gt; 8.2.2 Corticosteroids and other immunosuppressants</p></div></li></ul><ul><li><h3>BNF for Children (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13833-corticosteroids-and-other-immunosuppressants.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">8.2.2 Corticosteroids and other immunosuppressants</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13845-sirolimus.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">SIROLIMUS</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response &gt; 8.2.2 Corticosteroids and other immunosuppressants</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13846-rapamune.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rapamune®</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response &gt; 8.2.2 Corticosteroids and other immunosuppressants &gt; SIROLIMUS</p></div></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK1501.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Sirolimus</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; S</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/8273-e.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Sirolimus</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Immunosuppressants &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/08114.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rapamycin</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; R &gt; RA</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-S30.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Sirolimus</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; S</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E40E3E0R0D445.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Sirolimus</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; S</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>SIROLIMUS</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int921-sirolimus.htm">Sirolimus</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">prophylaxis of organ rejection in kidney allograft recipients (initially in combination with ciclosporin and corticosteroid, then with corticosteroid only); see also under Dose</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">monitor kidney function when given with ciclosporin; monitor whole blood-sirolimus trough concentration (Afro-Caribbean patients may require higher doses); hyperlipidaemia (monitor lipids); monitor urine proteins; increased susceptibility to infection (especially urinary-tract infection); increased susceptibility to lymphoma and other malignancies, particularly of the skin (limit exposure to UV light); <strong>interactions:</strong> Appendix 1 (sirolimus)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">monitor whole blood-sirolimus level closely and consult local treatment protocol; clearance reduced in mild to moderate impairment; in severe impairment decrease dose by 50% and monitor whole blood-sirolimus trough concentration every 5–7 days until 3 consecutive measurements have shown stable blood-sirolimus concentration</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">avoid unless essential—(toxicity in <em>animal</em> studies); effective contraception must be used during treatment and for 12 weeks after stopping</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">discontinue breast-feeding</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">abdominal pain, constipation, nausea, diarrhoea, ascites, stomatitis; oedema, tachycardia, hypertension, hypercholesterolaemia, hypertriglyceridaemia, venous thromboembolism; pleural effusion, pneumonitis; headache; pyrexia; proteinuria, haemolytic uraemic syndrome; anaemia, thrombocytopenia, thrombotic thrombocytopenic purpura, leucopenia, neutropenia, hypokalaemia, hypophosphataemia, hyperglycaemia, lymphocele; arthralgia, osteonecrosis; epistaxis; acne, rash, impaired healing; <em>less commonly</em> pancreatitis, pulmonary embolism, pulmonary haemorrhage, pericardial effusion, nephrotic syndrome, pancytopenia; <em>rarely</em> interstitial lung disease, alveolar proteinosis, hepatic necrosis, lymphoedema, and hypersensitivity reactions including anaphylactic reactions, angioedema, exfoliative dermatitis, and hypersensitivity vasculitis; focal segmental glomerulosclerosis and reversible impairment of male fertility also reported</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>Initially 6 mg, after surgery (once wound has healed), then 2 mg once daily (dose adjusted according to whole blood-sirolimus trough concentration) in combination with ciclosporin and corticosteroid for 2–3 months (sirolimus given 4 hours after ciclosporin); ciclosporin should then be withdrawn over 4–8 weeks (if not possible, sirolimus should be discontinued and an alternate immunosuppressive regimen used)</p></li>   </ul><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Manufacturer advises pre-dose (‘trough’) whole blood-sirolimus concentration (using <strong>chromatographic</strong> assay) when used with ciclosporin should be 4–12 micrograms/litre (local treatment protocols may differ); after withdrawal of ciclosporin pre-dose whole blood-sirolimus concentration should be 12–20 micrograms/litre (local treatment protocols may differ); close monitoring of whole blood-sirolimus concentration required if concomitant treatment with potent inducers or inhibitors of metabolism and after discontinuing them, or if ciclosporin dose reduced significantly or stopped; see also Hepatic Impairment above</p></div><p>When changing between oral solution and tablets, measurement of whole blood ‘trough’ sirolimus concentration after 1–2 weeks is recommended</p></div><div class="cG"><div class="cE"><h3 class="cT">Therapeutic drug monitoring assays</h3> <p class="cT">Sirolimus whole-blood concentration is measured using either high performance liquid chromatography (HPLC) or immunoassay. Switching between different immunoassays or between an immunoassay and HPLC can lead to clinically significant differences in results and therefore incorrect dose adjustments. Adjustment to the target therapeutic dose range should be made with knowledge of the assay used and corresponding reference range</p></div></div></div></div> </div><div id="pS"><p>Sub-sections</p><div id="PHP5638-rapamune" style="margin: 0 0 0 20px;"><h1 class="title">Rapamune® <span>(<a href="PHP10005-index-of-manufacturers.htm#PHP10399">Wyeth</a>)</span><span> <img src="images/pom_l.png" alt="Prescription only medicine" /></span></h1><div class="cU"><p><strong>Tablets</strong>, coated, sirolimus 500 micrograms (tan), net price 30-tab pack = £69.00; 1 mg (white), 30-tab pack = £86.49; 2 mg (yellow), 30-tab pack = £172.98. Counselling, administration</p><div class="cG"><div class="cE"><h3 class="cT">Important</h3> <p class="cT">The 500-microgram tablet is not bioequivalent to the 1-mg and 2-mg tablets. Multiples of 500 microgram tablets should <strong>not</strong> be used as a substitute for other tablet strengths</p></div></div></div><div class="cU"><p><strong>Oral solution</strong>, sirolimus 1 mg/mL, net price 60 mL = £162.41. Counselling, administration</p><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Contains ethanol</p></div></div><div class="cG"><div class="cE"><h3 class="cT">Counselling</h3> <p class="cT">Food may affect absorption (take at the same time with respect to food). Mix solution with at least 60 mL water or orange juice in a glass or plastic container immediately before taking; refill container with at least 120 mL of water or orange juice and drink immediately (to ensure total dose). Do not mix with any other liquids</p></div></div></div></div></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP5626-ciclosporin.htm">Previous: CICLOSPORIN</a> | <a class="top" href="PHP5638-rapamune.htm#">Top</a> | <a accesskey="]" href="PHP5639-tacrolimus.htm">Next: TACROLIMUS</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>